Pharmaceutical firms not included in President Trump's drug pricing agreements are now trying to negotiate their own deals. This move is aimed at avoiding potential tariffs and new pricing regulations. Industry insiders reveal that these companies are reaching out to the White House and Medicare off
Sixteen big drug companies made deals with the Trump administration to lower drug prices. But in January, all of them raised prices on some of their drugs. These deals were supposed to help Americans pay less for medicine and make other rich countries pay more. But according to a new report, these c
Two major drug companies, Lilly and Novo Nordisk, are close to striking a deal with the White House. They want to offer their weight loss drugs at a lower price. This is big news because it could mean more people can afford these medicines. The plan is to sell the lowest dose of their obesity drugs
